Related Experiment Video

Updated: Mar 6, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

2.8K

Methodological concerns regarding supraphysiological histidine concentrations in HCC immunometabolism studies: an

Chenyang Ma1, Xiaofei Zhu2

  • 1Department of Science and Education, Hangzhou Xiaoshan Second People's Hospital, Hangzhou, China.

Journal of Translational Medicine
|March 4, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

870

Related Experiment Videos

Last Updated: Mar 6, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

2.8K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

870

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

270
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
270

Articles linked to this work by shared authors, journal, and citation graph.

Corn Protein-Derived Bioactive Peptides Protect Gastric Epithelial Cells from Helicobacter pylori-Induced Injury by Alleviating Oxidative Stress, Mitochondrial Dysfunction, and Inflammation.

Foods (Basel, Switzerland)·2026

A novel perspective on the aging of raw Pu-erh tea: a comprehensive evaluation of the impact of different storage containers on flavor quality.

Food research international (Ottawa, Ont.)·2026

NMM-promoted decarboxylative C(sp3)-C(sp3) coupling of coumarin-3-carboxylic acids and indolin-3-ones.

Organic & biomolecular chemistry·2026

GSEA model outcomes in pharmaceutical workforce development: a retrospective pilot study (2023-2025).

Frontiers in public health·2026

A DAS-Based Multi-Sensor Fusion Framework for Feature Extraction and Quantitative Blockage Monitoring in Coal Gangue Slurry Pipelines.

Sensors (Basel, Switzerland)·2026

Synthesis of Carborane-Containing Flavone and Flavonol Analogues as ER Agonists and COX Inhibitors.

Journal of natural products·2026

SGLT2 inhibition improves sarcomere contractile dysfunction in human models of dilated cardiomyopathy.

Journal of translational medicine·2026

Human single-cell atlas of proliferative diabetic retinopathy reveals a SOX15-overexpressing stromal population driving retinal fibrosis through the endothelin-1 -EDNRB axis.

Journal of translational medicine·2026

Cross-trait genetic analysis maps shared polygenic architecture between primary aldosteronism and blood pressure to adrenal cell states.

Journal of translational medicine·2026

Gut microbiota-mediated neuroinflammation following stroke: mechanisms and intervention strategies.

Journal of translational medicine·2026

Umbilical cord-derived mitochondrial transplantation restores tendon structure and function in a preclinical model of achilles tendinopathy.

Journal of translational medicine·2026

Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.

Journal of translational medicine·2026

Prospective evaluation of imipenem trough concentrations and clinical outcomes in critically ill patients.

The Journal of antimicrobial chemotherapy·2026

Monotypic IgA nephropathy: A large health system experience.

Clinical nephrology·2026

Association of elevated homocysteine levels with renal pathology and function in patients with IgA nephropathy: a single-center retrospective study.

Annals of medicine·2026

Intestinal Ultrasound in Inflammatory Bowel Disease: Monitoring Inflammation and Treatment Response.

Journal of inflammation research·2026

Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

Open forum infectious diseases·2026

Breaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us